Different mechanisms were reported as cause of increased EZH2-dependent signaling in tumor cells, like gene mutations [101], amplification [102], certain transcriptional signals and pathways [103–105], hypoxia [106], and multiple microRNAs [107–109]. The gene discussed is EZH2; the disease is neoplasm.